Search Results - "Sabedot, Thais"
-
1
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Published in Nucleic acids research (05-05-2016)“…The Cancer Genome Atlas (TCGA) research network has made public a large collection of clinical and molecular phenotypes of more than 10 000 tumor patients…”
Get full text
Journal Article -
2
Glioma progression is shaped by genetic evolution and microenvironment interactions
Published in Cell (09-06-2022)“…The factors driving therapy resistance in diffuse glioma remain poorly understood. To identify treatment-associated cellular and genetic changes, we analyzed…”
Get full text
Journal Article -
3
Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications
Published in Neuro-oncology (Charlottesville, Va.) (09-04-2018)“…Gliomas are a heterogeneous group of brain tumors with distinct biological and clinical properties. Despite advances in surgical techniques and clinical…”
Get full text
Journal Article -
4
A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence
Published in Cell reports (Cambridge) (10-04-2018)“…Glioma diagnosis is based on histomorphology and grading; however, such classification does not have predictive clinical outcome after glioblastomas have…”
Get full text
Journal Article -
5
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas
Published in Neuro-oncology (Charlottesville, Va.) (05-09-2023)Get full text
Journal Article -
6
RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes
Published in Nucleic acids research (20-04-2018)“…Abstract We propose a generic framework for gene regulatory network (GRN) inference approached as a feature selection problem. GRNs obtained using Machine…”
Get full text
Journal Article -
7
A serum-based DNA methylation assay provides accurate detection of glioma
Published in Neuro-oncology (Charlottesville, Va.) (01-09-2021)“…Abstract Background The detection of somatic mutations in cell-free DNA (cfDNA) from liquid biopsy has emerged as a noninvasive tool to monitor the follow-up…”
Get full text
Journal Article -
8
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
Published in Cancer research (Chicago, Ill.) (04-03-2024)“…Tumor adaptation or selection is thought to underlie therapy resistance in glioma. To investigate longitudinal epigenetic evolution of gliomas in response to…”
Get full text
Journal Article -
9
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors
Published in Neuro-oncology (Charlottesville, Va.) (01-07-2022)“…Abstract Background DNA methylation abnormalities are pervasive in pituitary neuroendocrine tumors (PitNETs). The feasibility to detect methylome alterations…”
Get full text
Journal Article -
10
DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features
Published in Neuro-oncology (Charlottesville, Va.) (02-08-2021)“…Abstract Background Distinct genome-wide methylation patterns cluster pituitary neuroendocrine tumors (PitNETs) into molecular groups associated with specific…”
Get full text
Journal Article -
11
SIRT1 regulates Mxd1 during malignant melanoma progression
Published in Oncotarget (29-12-2017)“…In a murine melanoma model, malignant transformation promoted by a sustained stress condition was causally related to increased levels of reactive oxygen…”
Get full text
Journal Article -
12
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Published in Cell (28-01-2016)“…Therapy development for adult diffuse glioma is hindered by incomplete knowledge of somatic glioma driving alterations and suboptimal disease classification…”
Get full text
Journal Article -
13
Abstract 2085: The evolutionary trajectory of epigenomics in adult glioma
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Background: Glioma is the most common malignant tumor of the central nervous system, often behaving very aggressively. Recently, The Cancer Genome…”
Get full text
Journal Article -
14
EPCO-44. HOXD13 GENE PLAYS A ROLE AS A PUTATIVE MASTER EPIGENETIC REGULATOR IN GLIOMA RECURRENCE AND PROGRESSION
Published in Neuro-oncology (Charlottesville, Va.) (14-11-2022)“…Abstract BACKGROUND Adult diffuse glioma is a heterogenous brain tumor group that has malignant potential and recurring properties. Glioma CpG island…”
Get full text
Journal Article -
15
GENE-58. ACTIVE TRANSCRIPTION START SITES OF MENINGIOMA SAMPLES ASSOCIATED WITH RISK OF RECURRENCE
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2019)“…Abstract Meningiomas are mostly benign brain tumors but have a substantial risk of recurrence, sometimes to more aggressive subtypes. Recently, a DNA…”
Get full text
Journal Article -
16
Abstract 2717: Glioma immune microenvironment change during tumor recurrence
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Background: Gliomas are the most common malignant brain tumor, have a very aggressive behavior, and invariably relapse and progress. Despite the…”
Get full text
Journal Article -
17
Abstract 1640: Deep learning classification of neuro-oncology medical documents
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Introduction Precision medicine and big data for cancer discovery requires well curated indexed critical health care data, however to date limited…”
Get full text
Journal Article -
18
Abstract A12: DNA methylation-based liquid biopsy detects primary and recurrent meningioma
Published in Clinical cancer research (01-06-2020)“…Abstract Meningiomas are mostly benign CNS tumors; however, a subset of these tumors may become atypical or malignant. The standard of care to monitor patients…”
Get full text
Journal Article -
19
GENE-56. DEPLETION OF 5-HYDROXYMETHYLCYTOSINE IN AGGRESSIVE G-CIMP SUBTYPE
Published in Neuro-oncology (Charlottesville, Va.) (06-11-2017)“…5-hydroxymethylcytosine (5hmC) is an oxidation product of 5-methylcytosine, a reaction potentially mediated by the Tet family of enzymes. Levels of 5hmC were…”
Get full text
Journal Article -
20
Abstract 907: Bioinformatic method to define epigenetically regulated enhancer elements associated with cancer
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract BACKGROUND: Several mechanisms involved in gene regulation are altered in cancer. Cataloging these alterations can lead to a better understanding of…”
Get full text
Journal Article